Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. NuCana plc
  6. News
  7. Summary
    NCNA   US67022C1062

NUCANA PLC

(NCNA)
  Report
Delayed Nasdaq  -  03:59:01 2023-02-03 pm EST
1.600 USD   +3.23%
02/01Telecoms, Natural Resources Lead European Equities Lower in Wednesday Trading
MT
02/01Nucana : Presentation - February 2023
PU
01/31European Equities Rebound in Tuesday Trading as France Reports Growth
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Pharma, Tech Sectors Help Buoy American Depositary Receipts of European Stocks

12/08/2022 | 11:16am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AKARI THERAPEUTICS, PLC 4.62% 0.51 Delayed Quote.3.75%
AUTOLUS THERAPEUTICS PLC -1.93% 2.03 Delayed Quote.6.84%
BHP GROUP LIMITED -1.92% 47.91 Delayed Quote.5.00%
BICYCLE THERAPEUTICS PLC -3.55% 27.44 Delayed Quote.-7.30%
BIONTECH SE -1.62% 142.06 Delayed Quote.-5.43%
BRITISH AMERICAN TOBACCO (MALAYSIA) -1.53% 12.88 End-of-day quote.14.80%
BRITISH AMERICAN TOBACCO PLC 0.32% 3125.5 Delayed Quote.-4.75%
CARNIVAL CORPORATION -1.99% 11.8 Delayed Quote.46.40%
CREDIT SUISSE GROUP AG -1.07% 3.316 Delayed Quote.19.97%
CRITEO S.A. 0.38% 31.48 Delayed Quote.20.34%
MATERIALISE NV -1.33% 11.1 Delayed Quote.26.14%
NUCANA PLC 3.23% 1.6 Delayed Quote.142.42%
SANOFI -1.88% 85.14 Real-time Quote.-5.23%
SEQUANS COMMUNICATIONS S.A. 0.62% 3.24 Delayed Quote.-3.01%
TRINITY BIOTECH PLC -3.60% 1.07 Delayed Quote.8.08%
TRIVAGO N.V. -5.05% 1.88 Delayed Quote.39.26%
VEON LTD. 1.75% 0.6105 Delayed Quote.24.59%
All news about NUCANA PLC
02/01Telecoms, Natural Resources Lead European Equities Lower in Wednesday Trading
MT
02/01Nucana : Presentation - February 2023
PU
01/31European Equities Rebound in Tuesday Trading as France Reports Growth
MT
01/30European Equities Start the Week Modestly Higher Amid German GDP Contraction
MT
01/24Pharma Stocks Weigh Down European Equities in Tuesday Trading
MT
01/23NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
GL
01/23NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
AQ
01/20European Equities Nudge Lower in Friday Trading, With ADRs Ending Week Flat
MT
01/19Pharma Stocks Weigh Down European Equities in Thursday Trading
MT
01/18Tech Stocks Lead European Equities Modestly Higher in Wednesday Trading
MT
More news
Analyst Recommendations on NUCANA PLC
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -26,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -3,00x
Yield 2022 -
Capitalization 82,7 M 82,7 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 32
Free-Float 93,4%
Chart NUCANA PLC
Duration : Period :
NuCana plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NUCANA PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 1,60 $
Average target price 3,42 $
Spread / Average Target 114%
EPS Revisions
Managers and Directors
Hugh Stephen Griffith Chief Executive Officer & Executive Director
Donald Munoz Chief Financial Officer
Andrew Martin Kay Non-Executive Chairman
Theresa Margaret Bruce Senior Vice President-Clinical Operations
Elisabeth Oelmann Senior VP-Medical & Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
NUCANA PLC142.42%83
REGENERON PHARMACEUTICALS, INC.4.12%83 640
VERTEX PHARMACEUTICALS5.19%77 269
WUXI APPTEC CO., LTD.15.80%40 679
BIONTECH SE-5.43%34 523
BEIGENE, LTD.16.80%26 752